Regional Anesthesia in Pediatric Patients

Pediatric RA - Tiny Patients, Big Benefits

• Unique Physiology: ↑ CO, ↑ Vd (water-soluble drugs). Immature liver metabolism, ↓ protein binding → ↑ free drug. Nerves: less myelination → faster onset, shorter LA duration.
• Psychological: Address child/parent anxiety. Age-appropriate communication vital.
• Benefits: Superior opioid-sparing analgesia, ↓ stress response, faster recovery & ambulation, ↓ PONV.
• Pre-op: Parental consent, child assent (if able). Strict NPO adherence.

  ⭐ Local anesthetic systemic toxicity (LAST) risk is higher due to lower protein binding and immature metabolism; use dilute concentrations and weight-based dosing (e.g., Bupivacaine max 2-2.5 mg/kg).

LA Pharmacology - Dosing Little Ones

• LAs: Amides (Bupivacaine, Ropivacaine, Lidocaine) preferred over Esters.
• Pediatric PK: ↓ AAG (↑ free LA), slower clearance (neonates), larger Vd.
• Max Doses (mg/kg):
  • Bupivacaine: 2-2.5
  • Ropivacaine: 2-3
  • Lidocaine: 4-5 (plain); 7 (with epinephrine)
• Toxicity Signs: Often subtle. CNS (seizures, apnea), CVS (arrhythmias).

  ⭐ Neonates show ↑ bupivacaine cardiotoxicity risk (immature myocardium, slow clearance).

• Adjuvants (prolong analgesia):
  • Epinephrine (1-2 mcg/kg): Also ↓ absorption.
  • Clonidine (1-2 mcg/kg).
  • Dexmedetomidine (0.5-1 mcg/kg).

Peripheral Nerve Blocks - Targeting Tiny Nerves

Ultrasound guidance (USG) is paramount for safety and precision, allowing reduced local anesthetic volumes.

• Upper Limb:
  • Axillary: Common for forearm/hand; USG shows nerves clustered around axillary artery.
  • Supraclavicular: Effective but ⚠️ higher pneumothorax risk.
• Lower Limb:
  • Femoral: For anterior thigh/knee; USG: nerve lateral to femoral artery (mnemonic: NAVEL).
  • Fascia Iliaca: Wider sensory block than femoral alone.
  • Sciatic, Popliteal, Ankle blocks.
• Truncal:
  • TAP (Transversus Abdominis Plane): For abdominal wall analgesia.
  • Rectus Sheath, Ilioinguinal/Iliohypogastric blocks.

⭐ The use of ultrasound has significantly reduced the minimum effective anesthetic volume (MEAV$_{50}$) for many PNBs in children, enhancing safety.

Neuraxial Anesthesia - Spinal & Epidural Tales

• Caudal Epidural (Most Common)
  • Landmarks: Sacral hiatus, S4 cornua.
  • Dose: Bupivacaine 0.125-0.25%, 0.5-1 mL/kg.
  • 
• Lumbar/Thoracic Epidural
  • Less common; USG essential.
• Spinal Anesthesia (SAB)
  • For ex-premies (hernia repair, ↓ apnea).
  • ↑ CSF volume → ↑ LA dose (Bupivacaine 0.5-1 mg/kg).

  ⭐ Neonatal anatomy: Dural sac ends at L3 (adults: L1); Conus medullaris at L3 (adults: L1-L2).

Complications & Safety - Watching Out Carefully

• LA Systemic Toxicity (LAST): Critical concern.
  • Recognition (non-verbal/sedated): Agitation, seizures, arrhythmias, CV collapse.
  • Prevention: Ultrasound guidance (USG), incremental injection, aspiration.
  • Management:

• Other Complications:
  • Nerve injury (transient > permanent)
  • Hematoma/Bleeding
  • Infection (rare)
  • PDPH: Rare, atypical presentation in children.

⭐ In pediatric LAST, early signs can be subtle like agitation or drowsiness before progressing to seizures or cardiovascular compromise. Prompt recognition and Intralipid therapy are key.

• Anatomical variations (e.g., sacral hiatus, nerve depth) necessitate technique modification.
• Pharmacokinetics differ: ↑ Vd for LAs, immature metabolism demands precise mg/kg dosing.
• Caudal block is the most common pediatric regional technique.
• Ultrasound guidance (USG) is crucial for improving safety and success rates.
• Local anesthetic systemic toxicity (LAST) often presents with CNS excitation initially in children.
• Adjuvants like clonidine or dexmedetomidine significantly prolong analgesia.
• Key benefits include superior analgesia, opioid-sparing, and reduced PONV_._